首页 正文

Subcutaneous immunotherapy as a catalyst for decentralized, oncologist-led cancer care: a mixed-methods analysis

{{output}}
Background: The widespread adoption of immune checkpoint inhibitors has significantly improved outcomes across multiple solid tumors but has also increased pressure on hospital-based oncology services, particularly oncology day h... ...